https://www.eurekalert.org/news-releases/930295
News Release 4-Oct-2021
Reports and Proceedings
European College of Neuropsychopharmacology
The COVID pandemic has led to a significant increase in mental health problems. Now, in some good news, a pilot study has shown that depressed patients who have suffered from COVID respond better to standard antidepressants than do people who have not had COVID.
Around 40% of COVID sufferers report the development of depression within 6 months of infection. The inflammation caused by COVID is believed to be the main reason for the development of depression. Now new research has shown that around 90% of patients who have suffered from COVID respond to SSRIs, significantly more than would be expected.
-----
No comments:
Post a Comment